Ehlers-Danlos Syndromes: Prevalence, Types & Key Facts
The Ehlers-Danlos syndromes (EDS) are a group of 13 heritable connective tissue disorders caused by defects in collagen synthesis, structure, or processing. They share joint hypermobility, skin hyperextensibility, and tissue fragility but vary widely in severity and systemic involvement.
Prevalence
- Overall estimate: 1 in 5,000 (0.02%) for all types combined.
- Likely underdiagnosed: Milder forms (especially hypermobile EDS) often unrecognized.
- No ethnic/racial predilection.
The 13 Types (2017 Classification)
| Type | Gene(s) | Inheritance | Key Features |
|---|---|---|---|
| Hypermobile (hEDS) | Unknown | Autosomal dominant | Generalized joint hypermobility, chronic pain, fatigue, dysautonomia, GI issues. Most common (~80-90% of EDS). No molecular test. |
| Classical (cEDS) | COL5A1, COL5A2, COL1A1 | Autosomal dominant | Marked skin hyperextensibility, atrophic scars, joint hypermobility. 1:20,000-40,000. |
| Vascular (vEDS) | COL3A1 | Autosomal dominant | Arterial/intestinal/uterine rupture risk; thin translucent skin; characteristic facies. Life-threatening. 1:50,000-200,000. |
| Kyphoscoliotic (kEDS) | PLOD1, FKBP14 | Autosomal recessive | Severe hypotonia, kyphoscoliosis, scleral fragility, globe rupture risk. |
| Arthrochalasia (aEDS) | COL1A1, COL1A2 | Autosomal dominant | Congenital bilateral hip dislocation, severe hypermobility, skin fragility. |
| Dermatosparaxis (dEDS) | ADAMTS2 | Autosomal recessive | Extreme skin fragility, redundant skin, hernias. |
| Brittle Cornea Syndrome | ZNF469, PRDM5 | Autosomal recessive | Corneal thinning/rupture, keratoconus, blue sclerae. |
| Classical-like (clEDS) | TNXB | Autosomal recessive | Similar to cEDS but no atrophic scars; tenascin-X deficiency. |
| Spondylodysplastic (spEDS) | B4GALT7, B3GALT6, SLC39A13 | Autosomal recessive | Short stature, limb bowing, muscle hypotonia. |
| Musculocontractural (mcEDS) | CHST14, DSE | Autosomal recessive | Congenital contractures, craniofacial features, skin fragility. |
| Myopathic (mEDS) | COL12A1 | Autosomal dominant/recessive | Proximal muscle weakness, contractures, hypermobility. |
| Periodontal (pEDS) | C1R, C1S | Autosomal dominant | Severe early periodontitis, lack of attached gingiva, pretibial plaques. |
| Cardiac-valvular (cvEDS) | COL1A2 | Autosomal recessive | Progressive cardiac valve disease, joint hypermobility, skin involvement. |
Diagnosis & Management
- Clinical criteria for each type (2017 International Classification).
- Genetic testing confirms all except hEDS (clinical diagnosis).
- Multidisciplinary care: Genetics, rheumatology, physiatry, PT/OT, cardiology (vEDS), pain management, psychology.
- Surveillance: Vascular imaging (vEDS), DEXA, echocardiogram, ophthalmology.
- Avoid: Contact sports, heavy lifting, invasive procedures without precautions (vEDS).
Awareness Gaps
Delayed diagnosis averages 10-14 years. Clinician education, patient advocacy (Ehlers-Danlos Society), and research into hEDS genetics are priorities.
Genetic Disorders - Related Articles
- How Mutations Alter Signal Molecules: Structural, Functional, and Disease Consequences
- Parsonage-Turner Syndrome: Rare Brachial Neuritis Affecting 1-3 per 100,000
- Sickle Cell Anemia: Prevalence and At-Risk Populations
- Understanding and Managing Klinefelter Syndrome: A Comprehensive Guide
- Understanding and Managing Angelman Syndrome: A Comprehensive Guide
- Poland Syndrome: Understanding Causes, Symptoms & Treatment
- Parsonage-Turner Syndrome (Neuralgic Amyotrophy): Clinical Overview
